Sabby Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-3,013
Closed -$294K 241
2015
Q1
$294K Buy
+3,013
New +$294K 0.01% 109
2014
Q4
Sell
-145,200
Closed -$9.99K 186
2014
Q3
$9.99K Buy
+145,200
New +$9.99K 0.38% 7
2014
Q2
Sell
-13,538
Closed -$1.12M 169
2014
Q1
$1.12M Buy
+13,538
New +$1.12M 0.06% 48
2013
Q4
Hold
0
148
2013
Q3
Hold
0
139